Keywords: celgene, completes, trial, thalidomide, completed, pivotal, synovir

Celgene Completes Trial With Thalidomide

Article | 21 October 1996

Print This

- Celgene has completed a pivotal trial of Synovir (thalidomide) for severe weight loss associated with HIV infection, and says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in